Evaluating effects of risdiplam in adults with spinal muscular atrophy: a monocentric study
<b>In adults with SMA, risdiplam therapy may improve respiratory function. In these patients, sniff nasal inspiratory pressure is the most effective test to demonstrate effects of pharmacological therapy.</b> https://bit.ly/3Wk2MCU.
Authors
- Pierpaolo Alongi (ORCID: https://orcid.org/0000-0002-8397-1640)
- Grazia Crescimanno (ORCID: https://orcid.org/0000-0003-4830-9544)
- Filippo Brighina (ORCID: https://orcid.org/0000-0001-5875-3126)
- V. Tomasello
- Oreste Marrone (ORCID: https://orcid.org/0000-0001-6819-7928)
- Vincenzo Di Stefano (ORCID: https://orcid.org/0000-0001-9805-1655)
- Antonino Lupica (ORCID: https://orcid.org/0000-0003-1499-9460)
Institutions
- Institute for Biomedical Research and Innovation (IT)
- National Research Council (IT)
- University of Palermo (IT)
Publication Details
- Journal
- ERJ Open Research
- Published
- 2025-11-09
- DOI
- https://doi.org/10.1183/23120541.01120-2025
- Primary Topic
- Neurogenetic and Muscular Disorders Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00